Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme

2009 ◽  
Vol 65 (2) ◽  
pp. 391-397 ◽  
Author(s):  
Giulio Metro ◽  
Alessandra Fabi ◽  
Maria A. Mirri ◽  
Antonello Vidiri ◽  
Andrea Pace ◽  
...  
Keyword(s):  
Glioblastoma Multiforme ◽  
Dose Rate ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Fixed Dose ◽  
Newly Diagnosed ◽  
Fixed Dose Rate ◽  
Newly Diagnosed Glioblastoma

A phase II study of gemcitabine by fixed-dose rate infusion, cisplatin, and celecoxib in metastatic pancreatic cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4120-4120
Author(s):  
B. Kobrossy ◽  
B. F. El-Rayes ◽  
A. F. Shields ◽  
U. Vaishampayan ◽  
L. Heilbrun ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Dose Rate ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Pancreatic Cancer ◽  
Fixed Dose ◽  
Fixed Dose Rate ◽  
Fixed Dose Rate Infusion ◽  
Rate Infusion

A phase II study of gemcitabine by fixed-dose rate infusion, cisplatin, and celecoxib in metastatic pancreatic cancer

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4120-4120
Author(s):  
B. Kobrossy ◽  
B. F. El-Rayes ◽  
A. F. Shields ◽  
U. Vaishampayan ◽  
L. Heilbrun ◽  
...  
Keyword(s):  
Pancreatic Cancer ◽  
Dose Rate ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Pancreatic Cancer ◽  
Fixed Dose ◽  
Fixed Dose Rate ◽  
Fixed Dose Rate Infusion ◽  
Rate Infusion
Sign in / Sign up

Export Citation Format

Share Document